We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Contend Inter Partes Review Ignores Statutes, Skews Outcomes
Drugmakers Contend Inter Partes Review Ignores Statutes, Skews Outcomes
The formal process for disputing a patent before the U.S. Patent and Trademark Office skirts statutory requirements and provides drugmakers with an unfair proceeding that skews outcomes, industry said.